secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001558370-25-001879
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor reports Q4 GAAP net loss $296M, adjusted EPS $0.55; exploring sale of P&HS segment
--------------------------------------------------------------------------------

- Q4 GAAP net loss $296M ($3.84 loss per share); adjusted net income $43M ($0.55 EPS).
- Total revenue $2,696M in Q4, $10,701M for FY2024; adjusted EBITDA $138M Q4, $523M FY.
- Company actively engaging in discussions for potential sale of Products & Healthcare Services segment.
- Board authorized share repurchase program up to $100 million; also reduced debt $244M in 2024.
- 2025 guidance midpoint expects double-digit adjusted EBITDA and adjusted EPS growth, improving cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000155837025001879/0001558370-25-001879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000155837025001879/omi-20250228x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-001879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer